Impact of FDA Project Optimus Guidance on Early-Phase Trial Design - Vivek Subbiah
@viveksubbiah.bsky.social @fda.gov
oncodaily.com/voices/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
@viveksubbiah.bsky.social
Early Phase Drug Development; Oncologist; Precision Medicine; Phase 1 trials; AI & Precision Oncology; Clinical trials. Posts=My own
Impact of FDA Project Optimus Guidance on Early-Phase Trial Design - Vivek Subbiah
@viveksubbiah.bsky.social @fda.gov
oncodaily.com/voices/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/voices/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
โญ๏ธWhen AI rejects your grant proposal: algorithms are helping to make funding decisions
A foundation using an AI tool to screen grant applications says it makes the peer-review process more efficient, but other researchers say itโs a breakdown in trust
www.nature.com/articles/d41...
Appropriately critical commentary on cochrane reviews as the apply to matched targeted therapy by @viveksubbiah.bsky.social Journal of Clinical Oncology ascopubs.org/doi/full/10....
22.09.2025 21:17 โ ๐ 2 ๐ 3 ๐ฌ 0 ๐ 0PFS benefit noted with adagrasib
12.08.2025 02:40 โ ๐ 3 ๐ 1 ๐ฌ 1 ๐ 010 Must-Read Posts in Immuno-Oncology This Week
@viveksubbiah.bsky.social @jiajennyliu.bsky.social @gerryhanna.bsky.social @drjnaidoo.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmuneOncology
Nature Medicine Study on Molecular Profiling in Meningioma - @viveksubbiah.bsky.social
oncodaily.com/science/vive...
#OncoDaily #Oncology #Cancer #Health #Medicine
Rare Cancers Deserve Breakthroughs Too - Vivek Subbiah
@viveksubbiah.bsky.social @conquercancer.bsky.social
oncodaily.com/blog/rare-ca...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Top Articles Suggested by Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/voices/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
๐ Listen to Jiyoung Ahn, PhD, of New York University, discuss with @viveksubbiah.bsky.social, MD, about whether the oral bacterial and fungal microbiome is associated with the development of pancreatic #cancer.
Listen now: ja.ma/41Vzuh9
Congratulations to Petros Grivas on Being Named Medical Director of Fred Hutch Cancer Center - Vivek Subbiah
@viveksubbiah.bsky.social @fredhutch.org
oncodaily.com/career/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Top 5 Articles of the Week Suggested by Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/voices/vivek...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial - The Lancet www.thelancet.com/journals/lan...
11.08.2025 11:51 โ ๐ 5 ๐ 2 ๐ฌ 1 ๐ 1Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study - The Lancet Oncology www.thelancet.com/journals/lan...
11.08.2025 11:49 โ ๐ 5 ๐ 3 ๐ฌ 0 ๐ 0Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol - The Lancet Oncology www.thelancet.com/journals/lan...
11.08.2025 11:49 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0What is Missing to Fully Harness Precision Medicine and Transform Cancer Care - Vivek Subbiah
@viveksubbiah.bsky.social
@natmed.nature.com
oncodaily.com/blog/vivek-s...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PrecisionMedicine
Itโs Time We Evolve WHO Cancer Classification - Vivek Subbiah
@viveksubbiah.bsky.social
@who.int
oncodaily.com/science/vive...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CancerClassification #WHO
How Clinical Trials Offer Hope for Those Facing Limited Options - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/blog/clinica...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ClinicalTrial #Sarcoma #SarcomaAwarenessMonth
โญ๏ธTissue-agnostic cancer therapies: promise, reality, and the path forward
@natcomms.nature.com @ascocancer.bsky.social #ASCO25
www.nature.com/articles/s41...
๐จ Hot off the press! ๐จ The @myesmo.bsky.social ESMO Precision Oncology Working Group, has unveiled key "Recommendations for structuring Molecular Tumour Boards (MTBs) in clinical practice", now published in ESMO's flagship journal Annals of Oncology ๐งฌ๐ฅ
www.annalsofoncology.org/article/S092...
Cancer Isnโt Just a Human Disease โ Itโs a Biological Reality Across Species, From Dogs to Tigers to the Extinct Dinosaurs - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/blog/vivek-s...
#OncoDaily #Oncology #Cancer #Medicine #Health
25 Posts Not to Miss from EHA 2025
@nicogagelmann.bsky.social @talhabadarmd.bsky.social @majorajay.bsky.social @vincentrk.bsky.social @viveksubbiah.bsky.social @nejm.org
oncodaily.com/societies/eh...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EHA2025 #EHA25
Why Every Rare Cancer Patient Deserves Molecular Profiling? - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/insight/vive...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RareCancers #MolecularProfiling
Super interesting.
"Tissue-agnostic #cancer therapies promise 2 revolutionize oncology by targeting molecular drivers. [A] study of nearly 300K tumors found 21.5% w/tissue-agnostic indications. Despite 9 #FDA approvals, real-world implementation challenges ..." 1/2 #CanSky #OncSky #ASCO25
โญ๏ธTissue-agnostic cancer therapies: promise, reality, and the path forward
@natcomms.nature.com @ascocancer.bsky.social #ASCO25
www.nature.com/articles/s41...
ASCO and Google create โwalled gardenโ AI tool for doctors to query groupโs guidelines www.statnews.com/2025/05/21/a... via @statnews.com
22.05.2025 00:59 โ ๐ 4 ๐ 3 ๐ฌ 0 ๐ 0Honored to Work Alongside an Incredible Team of Investigators Dedicated to Ending Cancer - Vivek Subbiah
@viveksubbiah.bsky.social
oncodaily.com/blog/team-of...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ClinicalTrialsDay #ASCO25
Inspiring Journey of the 2024 Yvonne Awardees - A Year of Impact and Leadership
@drasyaagulnik.bsky.social
@viveksubbiah.bsky.social
oncodaily.com/blog/yvonne-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Yvonne #Leadership
โญ๏ธTo all the incredible moms who fill our lives with love, strength, and wisdom-today is for you.
๐๐ฝThank you for being the heart of every home & the foundation of so many dreams. Happy Motherโs Day! ๐โค๏ธ #MothersDay
Exhilarating discussions on new podcast: Immunoverse - Vivek Subbiah
@viveksubbiah.bsky.social @patrickhwumd.bsky.social @moffittnews.bsky.social
oncodaily.com/blog/immunov...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunoverse #Podcast